
Ankylosing Spondylitis Global Market Report 2023 Including: 1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery
Description
Ankylosing Spondylitis Global Market Report 2023
Including: 1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery2) By Molecule: Biologics; Biosimilar; Small Molecules3) By Route of Administration: Parenteral; Oral4) By Application: Juveniles; Adults5) By End User: Hospitals; Clinics; Research LaboratoriesrsCovering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG
Ankylosing Spondylitis Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ankylosing spondylitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ankylosing spondylitis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ankylosing spondylitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered:1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery
2) By Molecule: Biologics; Biosimilar; Small Molecules
3) By Route of Administration: Parenteral; Oral; Other Routes
4) By Application: Juveniles; Adults
5) By End User: Hospitals; Clinics; Research Laboratories; Other End Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Ankylosing Spondylitis Market Characteristics
- 3. Ankylosing Spondylitis Market Trends And Strategies
- 4. Ankylosing Spondylitis Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On Online Therapy Services Market
- 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
- 4.3. COVID-19 Impact On Online Therapy Services Market
- 5.1. Global Ankylosing Spondylitis Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
- 5.2. Global Ankylosing Spondylitis Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
- 5.3. Global Ankylosing Spondylitis Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market
- 6. Ankylosing Spondylitis Market Segmentation
- 6.1. Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
- Disease-Modifying Anti-Rheumatic Drugs (DMARDS)
- Biological Therapies
- Steroids
- Physical Therapies
- Surgery
- 6.2. Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Biologics
- Biosimilars
- Small Molecules
- 6.3. Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Parenteral
- Oral
- Other Routes
- 6.4. Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Juveniles
- Adults
- 6.5. Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals
- Clinics
- Research Laboratories
- Other End Users
- 7. Ankylosing Spondylitis Market Regional And Country Analysis
- 7.1. Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Ankylosing Spondylitis Market
- 8.1. Asia-Pacific Ankylosing Spondylitis Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.3. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.4. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Ankylosing Spondylitis Market
- 9.1. China Ankylosing Spondylitis Market Overview
- 9.2. China Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.3. China Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.4. China Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Ankylosing Spondylitis Market
- 10.1. India Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.2. India Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.3. India Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Ankylosing Spondylitis Market
- 11.1. Japan Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.2. Japan Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.3. Japan Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Ankylosing Spondylitis Market
- 12.1. Australia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.2. Australia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.3. Australia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Ankylosing Spondylitis Market
- 13.1. Indonesia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.2. Indonesia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.3. Indonesia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Ankylosing Spondylitis Market
- 14.1. South Korea Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.2. South Korea Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.3. South Korea Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Ankylosing Spondylitis Market
- 15.1. Western Europe Ankylosing Spondylitis Market Overview
- 15.2. Western Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.3. Western Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.4. Western Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Ankylosing Spondylitis Market
- 16.1. UK Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.2. UK Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.3. UK Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Ankylosing Spondylitis Market
- 17.1. Germany Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.2. Germany Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.3. Germany Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Ankylosing Spondylitis Market
- 18.1. France Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.2. France Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.3. France Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Italy Ankylosing Spondylitis Market
- 19.1. Italy Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.2. Italy Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.3. Italy Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Spain Ankylosing Spondylitis Market
- 20.1. Spain Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.2. Spain Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.3. Spain Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. Eastern Europe Ankylosing Spondylitis Market
- 21.1. Eastern Europe Ankylosing Spondylitis Market Overview
- 21.2. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.3. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.4. Eastern Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. Russia Ankylosing Spondylitis Market
- 22.1. Russia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.2. Russia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.3. Russia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. North America Ankylosing Spondylitis Market
- 23.1. North America Ankylosing Spondylitis Market Overview
- 23.2. North America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.3. North America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.4. North America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. USA Ankylosing Spondylitis Market
- 24.1. USA Ankylosing Spondylitis Market Overview
- 24.2. USA Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.3. USA Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.4. USA Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Canada Ankylosing Spondylitis Market
- 25.1. Canada Ankylosing Spondylitis Market Overview
- 25.2. Canada Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.3. Canada Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.4. Canada Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. South America Ankylosing Spondylitis Market
- 26.1. South America Ankylosing Spondylitis Market Overview
- 26.2. South America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.3. South America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.4. South America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Brazil Ankylosing Spondylitis Market
- 27.1. Brazil Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.2. Brazil Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.3. Brazil Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28. Middle East Ankylosing Spondylitis Market
- 28.1. Middle East Ankylosing Spondylitis Market Overview
- 28.2. Middle East Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.3. Middle East Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.4. Middle East Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29. Africa Ankylosing Spondylitis Market
- 29.1. Africa Ankylosing Spondylitis Market Overview
- 29.2. Africa Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.3. Africa Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.4. Africa Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 30. Ankylosing Spondylitis Market Competitive Landscape And Company Profiles
- 30.1. Ankylosing Spondylitis Market Competitive Landscape
- 30.2. Ankylosing Spondylitis Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Pvt. Ltd.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 31. Ankylosing Spondylitis Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb
- 31.2. Eli Lilly and Company
- 31.3. Gilead Sciences Inc.
- 31.4. Boehringer Ingelheim International GmbH
- 31.5. Amgen Inc.
- 31.6. Cedars-Sinai
- 31.7. Viatris Inc.
- 31.8. Astellas Pharma Inc.
- 31.9. Regeneron Pharmaceuticals Inc.
- 31.10. AstraZeneca plc
- 31.11. UCB Inc.
- 31.12. Cipla Inc.
- 31.13. Zydus Lifesciences Limited
- 31.14. Celltrion Inc.
- 31.15. Hetero Labs Ltd.
- 32. Global Ankylosing Spondylitis Market Competitive Benchmarking
- 33. Global Ankylosing Spondylitis Market Competitive Dashboard
- 34. Key Mergers And Acquisitions In The Ankylosing Spondylitis Market
- 35. Ankylosing Spondylitis Market Future Outlook and Potential Analysis
- 35.1 Ankylosing Spondylitis Market In 2027 - Countries Offering Most New Opportunities
- 35.2 Ankylosing Spondylitis Market In 2027 - Segments Offering Most New Opportunities
- 35.3 Ankylosing Spondylitis Market In 2027 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.